NCT00658892View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 8, 2008

Primary Completion Date

February 15, 2010

Study Completion Date

May 22, 2012

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

B7-DC cross-linking antibody rHIgM12B7

OTHER

flow cytometry

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER